
Sector: Retail / Pharmacy
ZA_CLS
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: yahoo_fundamentals_timeseries/CLS.JO
Monetary columns are in B ZAR, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueB ZAR | Operating profitB ZAR | D&AB ZAR | EBITDAB ZAR | Net profitB ZAR | Operating CFB ZAR | Capex + M&AB ZAR | AssetsB ZAR | EquityB ZAR | ROE (annualized) | Net debtB ZAR | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-28 | H1 2026 (6M) | OK | 24.9 y/y 7.4% | 2.3 y/y 7.4% | 1.0 y/y 9.5% | 3.3 y/y 8.1% | 1.5 y/y 6.6% | 1.0 | -0.3 | 23.0 y/y 11.1% | 6.1 y/y -4.6% | 47.2% | 3.2 | Link |
| 2025-08-31 | H2 2025 (6M) | OK | 24.7 y/y 4.4% | 2.6 y/y 11.4% | 0.8 y/y -6.7% | 3.4 y/y 6.3% | 1.8 y/y 15.1% | 4.3 | -0.8 | 22.6 y/y 8.5% | 6.9 y/y 9.1% | 48.9% | ≈ 2.4 | Link |
| 2025-02-28 | H1 2025 (6M) | OK | 23.2 y/y 6.2% | 2.1 y/y 12.6% | 0.9 y/y 7.6% | 3.0 y/y 11.0% | 1.4 y/y 12.9% | 1.0 | -0.2 | 20.7 y/y 11.4% | 6.4 y/y 22.1% | 45.3% | 2.4 | Link |
| 2024-08-31 | H2 2024 (6M) | OK | 23.6 y/y 9.3% | 2.3 y/y 16.2% | 0.9 y/y 15.3% | 3.2 y/y 15.9% | 1.6 y/y 13.0% | 1.9 | -0.6 | 20.8 y/y 9.4% | 6.3 y/y 5.4% | 49.2% | 1.1 | Link |
| 2024-02-29 | H1 2024 (6M) | OK | 21.8 y/y 9.0% | 1.9 y/y 13.5% | 0.9 y/y 14.1% | 2.7 y/y 13.7% | 1.3 y/y 10.4% | 1.1 | -0.3 | 18.6 y/y 6.5% | 5.2 y/y -8.6% | 45.4% | ≈ 0.8 | Link |
| 2023-08-31 | H2 2023 (6M) | OK | 21.6 y/y — | 2.0 y/y — | 0.8 y/y — | 2.8 y/y — | 1.4 y/y — | 2.3 | -0.6 | 19.0 y/y — | 6.0 y/y — | 43.4% | 0.8 | Link |
| 2023-02-28 | H1 2023 (6M) | OK | 20.0 y/y — | 1.6 y/y — | 0.7 y/y — | 2.4 y/y — | 1.2 y/y — | 1.0 | -0.4 | 17.5 y/y — | 5.7 y/y — | — | — | Link |
Quarterly values (ZAR mln)
Year-over-year change
FCF (ZAR mln)
Net debt / cash (ZAR mln)
| year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| cash flow / profit | 1.26x | 0.73x | 1.30x | 1.06x | 1.62x |
| accruals, % of assets | -2.8% | 4.0% | -4.1% | -0.8% | -8.9% |
Value the company creates per year, as a % of market cap
Value created per year: +6.4%
| 1. EBITDA growth (latest quarter YoY, annualised) [EBITDA latest qtr − EBITDA year-ago qtr] × annualisation X (2026-02-28 vs 2025-02-28) = (3 256 − 3 013) × 2.05 | 497 |
| 2. Current EV/EBITDA (LTM) (Market cap + Net debt) ÷ EBITDA (LTM) = (49 642 + 3 176) ÷ 6 661 | 7.9x |
| 3. Target multiple (Current EV/EBITDA + 8) ÷ 2 = (7.9 + 8) ÷ 2 | 8.0x |
| 4. Cash flow (balance method, LTM) Net-debt reduction + dividends + buybacks − equity issuance = -803 + 0 + 0 − 0 | -803 |
| 5. Value created per year (EBITDA growth × Target multiple + Cash flow − Dilution) ÷ Market cap = (497 × 8.0 + -803) ÷ 49 642 | +6.4% |
Amounts in millions of the reporting currency. EBITDA growth is the latest quarter vs the same quarter a year ago, annualised.
Caveats:
| Date | Per share | Details | Status | Source |
|---|---|---|---|---|
| 2026-07-01 | 258 ZAR | Ex-dividend: 258 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2026-01-21 | 648 ZAR | Ex-dividend: 648 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2025-07-02 | 238 ZAR | Ex-dividend: 238 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2025-01-22 | 566 ZAR | Ex-dividend: 566 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2024-06-26 | 210 ZAR | Ex-dividend: 210 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2024-01-24 | 494 ZAR | Ex-dividend: 494 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2023-06-28 | 185 ZAR | Ex-dividend: 185 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2023-01-25 | 457 ZAR | Ex-dividend: 457 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2022-06-29 | 180 ZAR | Ex-dividend: 180 ZAR per share | Paid | Yahoo Finance (ex-div) |
| 2022-01-26 | 347.5 ZAR | Ex-dividend: 347.5 ZAR per share | Paid | Yahoo Finance (ex-div) |
KASE: status follows wording in the news headline (paid vs intends to pay). Yahoo: amounts are cash dividends per share on ex-dividend dates (UTC calendar date). stockscope.uz (UZ): amounts are per share in UZS by publication date (not necessarily ex-div).
Investor reporting (IR): https://www.clicksgroup.co.za/investors/
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)
Financial results, valuation multiples (P/E, P/B, EV/EBITDA), profitability and dividend yield of Clicks Group (CLS) — from primary filings.
Clicks Group is a South African retailer specializing in health, wellness, and beauty products, operating through retail stores and a pharmaceutical distribution segment.
See also: South African Stocks (2026): Gold, Cheap Banks and the JSE Discount · The Cheapest Stocks in the World (2026): What Value Investing Says About Buying Cheap · global valuation map